- Home
- SIEB vs IMA Comparison
SIEB vs IMA Comparison
Compare SIEB & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIEB | IMA |
|---|---|---|
| Founded | 1886 | 2019 |
| Country | United States | United States |
| Employees | N/A | 17 |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 66.3M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | SIEB | IMA |
|---|---|---|
| Price | $1.87 | $5.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 39.1K | 37.6K |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $94,202,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.28 | N/A |
| 52 Week Low | $1.68 | $3.94 |
| 52 Week High | $5.46 | $17.50 |
Technical Indicators
Market Signals| Indicator | SIEB | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 48.02 |
| Support Level | $1.88 | $5.23 |
| Resistance Level | $1.97 | $6.12 |
| Average True Range (ATR) | 0.14 | 0.34 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 32.09 | 42.31 |
Price Performance
Historical ComparisonAbout SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm engaged in providing brokerage and financial advisory services. The coperates through two segments: Financial Services and Media, Sports and Entertainment. The Financial Services segment mainly operates as a securities broker-dealer and provides brokerage, custody, and clearing services for retail accounts, as well as insurance and advisory services, principal and proprietary trading, market making, securities lending, and investment banking and capital markets services. The Media, Sports and Entertainment segment is engaged in the production and distribution of music and media content, as well as talent management and sports representation. It generates the majority of its revenue from the Financial Services segment.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.